Dr. José Miguel Láinez Andrés

Investigador Principal
Grupo Clínico Asociado en Neurorología

Presentación

Dr. José Miguel Láinez Andrés
Investigador
Principal
Dr. José Miguel Láinez Andrés

j.miguel.lainez@uv.es, lainez_jos@gva.es, miguel.lainez@sen.es

Publicaciones
Calcitonin gene-related peptide in migraine: from pathophysiology to treatment. Santos-Lasaosa S, Belvis R, Cuadrado M, Diaz-Insa S, Gago-Veiga A, Guerrero-Peral A, Huerta M, Irimia P, Lainez J, Latorre G, Leira R, Pascual J, Porta-Etessam J, Sanchez Del Rio M, Viguera J, Pozo-Rosich P. Neurologia. 2022 Jun;37(5):390-402. doi: 10.1016/j.nrleng.2019.03.025. PMID: 35672126

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress. Lainez J, Ashina M, Belvis R, Diaz-Insa S, Ezpeleta D, Garcia-Azorin D, Gonzalez-Oria C, Guerrero A, Guillem A, Holle-Lee D, Huerta-Villanueva M, Irimia P, Leira R, Pascual J, Porta-Etessam J, Pozo-Rosich P, Rodriguez-Vico J, Sanchez del Rio M, Santos-Lasaosa S, Silberstein S. Revista de Neurologia. 2021 Jun 30;72(s02):S1-S19. doi: 10.33588/rn.72s02.2021155. PMID: 34180043

Document of revision and updating of medication overuse headache (MOH). Gonzalez-Oria C, Belvis R, Cuadrado M, Diaz-Insa S, Guerrero-Peral A, Huerta M, Irimia P, Lainez Andrés J, Latorre G, Leira R, Oterino A, Pascual J, Porta-Etessam J, Pozo-Rosich P, Sanchez Del Rio M, Santos-Lasaosa S. Neurologia. 2021 Apr;36(3):229-240. doi: 10.1016/j.nrl.2020.04.029. PMID: 32917437

Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery. Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich P, Lainez Andrés J. Neurologia. 2021;36(1):61-79. doi: 10.1016/j.nrl.2020.04.022. PMID: 32718873

Rituximab for the treatment of generalised myasthenia gravis: experience in clinical practice. Martinez-Monte E, Gascon-Gimenez F, Dominguez-Moran JA, Lainez-Andres JM. Revista de Neurologia. 2021 Nov 16;73(12):416-420. doi: 10.33588/rn.7312.2021166. PMID: 34877644

The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish. Gallardo V, Alpuente A, Cerda-Company X, Torres-Ferrus M, Del Rio M, Lainez J, Leira R, Trochet J, Pozo-Rosich P. Headache. 2021 Oct;61(9):1403-1410. doi: 10.1111/head.14225. PMID: 34601726

Tinnitus and tinnitus disorder: Theoretical and operational definitions (an international multidisciplinary proposal). De Ridder D, Schlee W, Vanneste S, Londero A, Weisz N, Kleinjung T, Shekhawat G, Elgoyhen A, Song J, Andersson G, Adhia D, de Azevedo A, Baguley D, Biesinger E, Binetti A, Del Bo L, Cederroth C, Cima R, Eggermont J, Figueiredo R, Fuller T, Gallus S, Gilles A, Hall D, Van de Heyning P, Hoare D, Khedr E, Kikidis D, Kleinstaeuber M, Kreuzer P, Lai J, Lainez J, Landgrebe M, Li L, Lim H, Liu T, Lopez-Escamez J, Mazurek B, Moller A, Neff P, Pantev C, Park S, Piccirillo J, Poeppl T, Rauschecker J, Salvi R, Sanchez T, Schecklmann M, Schiller A, Searchfield G, Tyler R, Vielsmeier V, Vlaeyen J, Zhang J, Zheng Y, de Nora M, Langguth B. Progress in Brain Research. 2021;260:1-25. doi: 10.1016/bs.pbr.2020.12.002. PMID: 33637213

An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection. Gomez-Iglesias P, Porta-Etessam J, Montalvo T, Valls-Carbo A, Gajate V, Matias-Guiu J, Parejo-Carbonell B, Gonzalez-Garcia N, Ezpeleta D, Lainez Andrés J, Matias-Guiu J. Frontiers in Public Health. 2020 May 29;8:243. doi: 10.3389/fpubh.2020.00243. PMID: 32574308

Evaluation of the concomitant use of oral preventive treatments and Onabotulinumtoxin A in chronic migraine: the PREVENBOX study. Alpuente A, Gallardo V, Torres-Ferrus M, Santos-Lasaosa S, Guerrero A, Lainez Andrés J, Viguera J, Gago-Veiga A, Irimia P, Del Rio M, Pozo-Rosich P. European Journal of Neurology. 2020 Oct;27(10):2102-2108. doi: 10.1111/ene.14331. PMID: 32421912

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine. Santos-Lasaosa S, Cuadrado M, Gago-Veiga A, Guerrero-Peral A, Irimia P, Lainez Andrés J, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera Romero J, Pozo-Rosich P. Neurologia. 2020 Oct;35(8):568-578. doi: 10.1016/j.nrl.2017.09.003. PMID: 29169811

Will neurological care change over the next 5 years due to the COVID-19 pandemic?. Matias-Guiu J, Matias-Guiu J, Alvarez-Sabin J, Ramon Ara J, Arenillas J, Casado-Naranjo I, Castellanos M, Jimenez-Hernandez M, Lainez Andrés J, Moral E, Morales A, Rodriguez-Antiguedad A, Segura T, Serrano-Castro P, Diez-Tejedor E. Neurologia. 2020 May;35(4):252-257. doi: 10.1016/j.nrl.2020.04.006. PMID: 32364126

+ Información
Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery. Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich P, Lainez Andrés J. Neurologia. 2021;36(1):61-79. doi: 10.1016/j.nrl.2020.04.022. PMID: 32718873